Trial Profile
BOSENTAN FOR THE TREATMENT OF SKIN ULCERS IN DIABETIC MICROANGIOPATHY [Bosentan zur Behandlung von Hautulzera bei diabetischer Mikroangiopahtie]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2012
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- 04 Apr 2012 New trial record